Pfizer decides on minority stake in $295mn Chinese JV with Hisun
This article was originally published in Scrip
Executive Summary
Pfizer and Zhejiang Hisun Pharmaceutical have decided upon some of the additional details of their planned Chinese joint venture, including the total amount of investment, which will be $295 million.